# SYNDROS
> **NDA205525** · New Drug Application · Sponsor: WELLHOUSE PHARMA · Approved 2016-07-01
## Drug
- **FDA Application Number:** NDA205525
- **Application type:** New Drug Application
- **Brand name:** SYNDROS
- **Generic name:** DRONABINOL
- **Active ingredients:** DRONABINOL
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** WELLHOUSE PHARMA
- **Manufacturer:** Wellhouse Pharma, LLC
- **First approval:** 2016-07-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205525)
---
*AI Analytics · CC0 1.0*